Ketamine Opens a Window - Integration Therapy Is What You Do with It

What really is Ketamine?

Maybe you have heard about ketamine through your doctor or headlines about its rapid antidepressant effects. Maybe someone you know tried it and said it changed their life — or said it helped for a while and then the darkness came back.

Why is it that some people rave about their life change and then others say the benefits don’t last? This requires understanding something that often gets left out of the conversation entirely: integration. This is huge. But first —

What Ketamine Actually Does in the Brain

Ketamine is not a new drug. It has been used as an anesthetic in human and veterinary medicine for decades. But in 2019, the FDA approved a ketamine-derived nasal spray as a fast-acting antidepressant — a significant moment in mental health treatment.

What makes ketamine different from traditional antidepressants is speed and mechanism. Traditional antidepressants can take weeks to work. Ketamine’s effects can be felt within hours.

Harvard Medical School researchers at Massachusetts General Hospital recently traced exactly how this happens. Ketamine affects three key regions of the brain. Two are believed to play a role in its antidepressant effects — the prefrontal cortex, responsible for planning and executive function, and the hippocampus, which influences memory formation.

This is significant. Depression is not simply sadness — it involves a disruption in how the brain processes thought, memory, and meaning. Ketamine appears to act directly on those systems.

The clinical evidence is compelling. In a clinical trial of 403 patients published in the New England Journal of Medicine, researchers found that 55 percent of those who received ketamine treatment experienced sustained improvement in depressive symptoms without major side effects — results comparable to electroconvulsive therapy, which has been the gold standard for treating severe depression for over 80 years.

The Window — And Why It Matters

So now ketamine treatment opens a window in the brain — but can one keep it open moving forward? Here is what the headlines often miss.

Ketamine creates what researchers describe as a period of increased neuroplasticity — a window of time when the brain is more open to change, new patterns, and new ways of thinking. This window is real and it is valuable. But it is just that: a window.

Research helps explain exactly why this window exists at a biological level. Ketamine works primarily on the glutamatergic system — the brain’s most widespread neurotransmitter network. Studies show that a single dose of ketamine promotes neurogenesis in the adult hippocampus as well as an increase in dendritic spines and synaptic density within the prefrontal cortex — changes that often correlate with improvements in depressive symptoms.

In plain language: ketamine can literally help rebuild connections in a brain that depression has worn down. But those new connections are raw and unformed. Neuroplasticity creates capacity, not instant therapeutic change. The new neural pathways require targeted input from psychotherapy, behavioral work, and environmental reinforcement to become stable and functional.

These experiences of non-ordinary consciousness are believed to lead to a period of increased neuroplasticity that lasts for anywhere from a few days to a month or so. Integrating during this time allows you to explore and process the immediate insights and emotions while they are still fresh, while taking advantage of this period of receptivity to change.

What you do with that window determines whether the experience becomes lasting transformation — or simply a temporary lift that fades.

This is the piece that most ketamine providers don’t have time to address. And it is precisely where integration therapy comes in.

What Is Integration Therapy?

Integration therapy is the structured, intentional work of making sense of a profound experience and bringing its insights into your daily life.

According to the Multidisciplinary Association for Psychedelic Studies — MAPS — one of the leading organizations in psychedelic research and education, integration is a process in which a person revisits and actively engages in making sense of, working through, translating, and processing the content of their psychedelic and non-ordinary consciousness experience. Through intentional effort and supportive practices, this process allows one to gradually capture and incorporate the emergent lessons and insights into their lives, moving toward greater balance and wholeness — internally in mind, body, and spirit, and externally in lifestyle, relationships, and connection to the natural world.

In plain language: the ketamine session is not the healing. It is the opening. Integration therapy is the healing.

Without active effort, valuable lessons tend to fade, and difficult experiences can reinforce traumas or existing patterns and defenses. Rather than doing the healing for us, psychedelics may give us an experience of and orientation toward wholeness, along with insight into the barriers and misalignments that will need to be addressed to continue toward or maintain that wholeness.

Researchers at the Ketamine Research Foundation writing in Frontiers in Psychiatry put it plainly: providing ketamine without psychotherapeutic engagement misses the opportunity for a therapeutic encounter that opens the door to personal change — leaving patients in the hole of “what happened to me?” — especially those new to altered states, who are left with an inexplicable, uncommunicated, or unvalidated realm of experience.

The same researchers note that follow-up and near-term integrative sessions are essential for support of patients, their reframing of their stories, assistance with confusion that may arise from such powerful experiences, and for the positive effects that come from the therapeutic relationship — especially the arising of trust.

What Integration Therapy Actually Looks Like

Integration is not one thing. It is a process that unfolds across multiple dimensions of a person’s life.

MAPS describes a synthesized model that covers six domains where integration work happens: mind, body, spirit, relationships, lifestyle, and connection to nature. Each area matters. A ketamine experience that surfaces insights about your relationships, for example, needs to be actively worked with in the context of those relationships — not just noted and set aside.

In my work as a licensed mental health counselor and trauma-informed integration practitioner, sessions typically involve:

Meaning making — What did the experience bring up? What does it mean for how you’ve been living, relating, or coping?

Emotional processing — Ketamine can surface grief, fear, joy, or long-buried memories. Having a trained therapist to work through these is not optional — it is essential.

Somatic integration — The body holds the experience. Breathwork, mindfulness, and somatic awareness practices help anchor insights at a physical level, not just a cognitive one.

Behavioral translation — Insights without action fade. We work together to identify what specifically needs to change in your daily life, relationships, or patterns — and build a realistic path toward those changes.

Integration is not a one-time event but an ongoing process. It may include mindfulness, meditation, yoga, creative expression, or any other activities that support mental and emotional well-being. Consistent practice can help reinforce and deepen the integration process — and we may continue to integrate just one profound experience for years, or even the rest of our lives.

A Word About Realistic Expectations

Ketamine is not a shortcut. It is not a cure. And it is not the same experience for everyone.

The drug also has dissociative effects including hallucinations that vary significantly between individuals — some patients experience them intensely, others less so. These experiences can be disorienting, emotionally intense, or spiritually significant. They deserve proper support — before, during, and after. Ketamine can also be an addictive drug and therefore should be administered through a trained and licensed professional.

The clinical data supports this clearly. An analysis of over 200 patients found that ketamine-assisted psychotherapy — pairing ketamine with structured psychotherapeutic support — was effective in treating depression, anxiety, PTSD, and substance use, with patients demonstrating significant improvements in well-being. These outcomes are meaningfully better than ketamine administered without therapeutic support.

Research also shows that preparation of mindset supported therapeutic benefit, underscored by openness, clear therapeutic intentions, mindfulness, and understanding how the process works. Comfort in the setting supported participants to “let go” — facilitated by a strong therapeutic alliance and feeling genuinely safe.

In other words — how you enter the experience, and what support surrounds it, shapes what you get from it.

Responsible researchers are clear about this. While ketamine has real utility for the right patient in an appropriate setting, there is also real concern about the potential for misuse and the proliferation of providers with varying protocols and degrees of regulation.

The person who approaches ketamine looking for the biggest impact for the least investment — financially, emotionally, or in terms of follow-up work — is likely to be disappointed. The research is consistent: outcomes improve dramatically when the experience is held within a container of preparation and integration support.

Who Is a Good Candidate for Integration Support?

You may benefit from working with an integration therapist if:

• You are preparing for a ketamine series and want to maximize its therapeutic potential
• You have completed ketamine treatment and feel like something important came up that you haven’t fully processed
• You had a difficult or confusing experience and need support making sense of it
• You want the insights from your experience to translate into actual, lasting change in your life
• You are navigating anxiety, depression, trauma, or life transitions and are considering ketamine as part of a broader healing approach

Integration support is not only for people in crisis. It is for people who take their healing seriously.

My Approach

I am a licensed mental health counselor (LMHC, LCMHC) licensed in Florida and Vermont, trained in trauma-informed care, somatic therapy, and psychedelic preparation and integration. I work with adults — particularly high-achieving women navigating anxiety, burnout, and major life transitions — who are ready to do the deeper work that lasting change requires.

I do not administer ketamine or any other substance. My role is to help you prepare intentionally, process what arises, and integrate the experience into a life that actually feels different.

If you are curious about whether integration support is right for you, I offer a free 15-minute consultation. No pressure — just a conversation.

→ Book your free consultation at meganholleran.com

Megan Holleran, LMHC, LCMHC is a licensed mental health counselor in Florida and Vermont specializing in anxiety, trauma, perimenopause, and psychedelic integration. She offers telehealth statewide and coaching worldwide.

This post is for informational purposes only and does not constitute medical or clinical advice. If you are experiencing a mental health crisis please contact a qualified healthcare provider or call 988, the Suicide and Crisis Lifeline.

Sources

• Harvard Gazette / Massachusetts General Hospital (May 31, 2023) — brain regions and clinical trial data
• New England Journal of Medicine — ketamine vs. ECT clinical trial, 403 patients
• Wolfson & Vaid, Frontiers in Psychiatry (2024) — ketamine-assisted psychotherapy and the value of subjective experience
• Dore, Turnipseed, Wolfson et al., Journal of Psychoactive Drugs (2019) — KAP outcomes across three large practices
• MAPS Integration Station — synthesized model of psychedelic integration (Bathje, Majeski & Kudowor, 2022)
• Harvard Health (2023) — ketamine safety and FDA guidance on compounded products

Next
Next

Lack is a Lie